This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignees: Charité – Universitätsmedizin Berlin, Max-Delbrueck-Centrum Fuer Molekulare Medizin, Berlin Cures Gmbh. Active years: 2005-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 283 
2 out of 18 
1 out of 1 Years Active: 2005-2021
Title: Annekathrin Haberland: Innovator in Aptamer Technology
Introduction
Annekathrin Haberland is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of molecular medicine, particularly through her work on aptamers. With a total of five patents to her name, her innovations are paving the way for new therapeutic approaches.
Latest Patents
Haberland's latest patents include groundbreaking inventions such as "Aptamers for use in inhibition and/or suppression of TLR9 activation." This invention focuses on new aptamer molecules designed to inhibit or suppress TLR9 activation in cells, offering potential therapeutic benefits. Another notable patent is "Use of aptamers in therapy and/or diagnosis of autoimmune diseases." This invention targets various autoimmune conditions, including cardiomyopathy and Alzheimer's disease, utilizing specific nucleic acid sequences for diagnosis and treatment.
Career Highlights
Throughout her career, Annekathrin Haberland has worked with esteemed institutions such as the Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin. Her research has significantly advanced the understanding and application of aptamer technology in medical science.
Collaborations
Haberland has collaborated with notable colleagues, including Ingolf Schimke and Gerd Wallukat. These partnerships have further enriched her research and contributed to her innovative work in the field.
Conclusion
Annekathrin Haberland's contributions to aptamer technology exemplify her dedication to advancing medical science. Her patents reflect a commitment to developing innovative solutions for complex health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile